Jane Street
EVGN icon

Jane Street’s Evogene EVGN Stock Holding History

Jane Street’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,040
Closed -$103K – 9922
2021
Q1 		$103K Buy
+2,040
New +$126K ﹤0.01% 8633

Other funds holding EVGN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TCM
Tradewinds Capital Management Bellingham, Washington $563M AUM 41.52% 1-Year Est. Return

Jane Street's EVGN Position: Q1 2026 in Review

Jane Street reduced its Evogene (EVGN) stake by 51% in Q1 2026, selling an estimated $18.4K and leaving 18,500 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #11257.

Jane Street first reported a position in EVGN in Q1 2014 and has held it in 28 quarters since. The position peaked at $825K in Q4 2020. 15 funds tracked by Wall St. Rank hold EVGN as of Q1 2026.

  • Jane Street held 18,500 shares of Evogene worth $14.2K as of Q1 2026.
  • Jane Street sold 19,442 Evogene shares in Q1 2026, an estimated $18.4K.
  • Evogene made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11257 holding.
  • Jane Street first reported a position in Evogene in Q1 2014 and has held it in 28 quarters since.
  • Jane Street's Evogene position peaked at $825K in Q4 2020.
  • 15 funds tracked by Wall St. Rank held Evogene as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.